<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01723215</url>
  </required_header>
  <id_info>
    <org_study_id>TelAvivU</org_study_id>
    <nct_id>NCT01723215</nct_id>
  </id_info>
  <brief_title>Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial</brief_title>
  <official_title>Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Corps, Israel Defense Force</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Walter Reed Army Institute of Research (WRAIR)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Tel Aviv University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Military deployment to combat zones involves exposure to trauma at a higher than average rate
      and therefore presents a unique opportunity to study predisposing factors to posttraumatic
      stress reactions and test strategies designed to prevent and ameliorate posttraumatic
      symptoms. Decades of scientific research on the origins of resilience and vulnerability to
      combat-related posttraumatic stress symptoms revealed various predisposing and protective
      factors. All these factors however, offer limited opportunity for systematic pre-deployment
      prevention efforts. Considering the magnitude of psychological adjustment difficulties
      encountered by combat personnel in deployment and the limited access to existing
      evidence-based therapies for PTSD, the development and testing of a novel evidence-based and
      theory-driven prevention protocol for these problems is of considerable significance. The
      current study translates cognitive-neuroscience knowledge and attention bias modification
      research into a novel computerized training tool that could be easily delivered to soldiers
      during different stages of the deployment cycle. If proved efficacious in reducing risk for
      posttraumatic symptoms ABMT could be integrated into the Army's resilience training program.
      Thus, we propose a longitudinal double-blind randomized controlled study of ABMT in soldiers.
      We will assess attention bias and symptoms before deployment, will randomly assign soldiers
      to either 8 ABMT sessions, 4 ABMT sessions, 8 Placebo training sessions, or no training.
      Following 6 months of deployment to combat zone symptoms will be assessed again.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in PTSD symptoms(PCL)</measure>
    <time_frame>Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat</time_frame>
    <description>1. pre-treatment 2.after first deployment 3.10 days after combat 4. 4 months after combat</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probable PTSD diagnosis(CAPS)</measure>
    <time_frame>Four months after combat</time_frame>
    <description>Four months after combat</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Depression(PHQ-9)) and Anxiety(STAI)</measure>
    <time_frame>Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat</time_frame>
    <description>1. Pre-treatment(baseline) 2.after first deployment 3.10 days after combat 4. 4 months after combat</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Attention Bias Scores</measure>
    <time_frame>Pre-traetment baseline and in deployment</time_frame>
    <description>Attention bias scores measured in milliseconds using the dot-probe task</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">862</enrollment>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>Active ABMT8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active ABMT8 8 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active ABMT4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active ABMT4 4 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control: will not receive any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo: will receive 4 training sessions(10 min. each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active ABMT8</intervention_name>
    <description>Active ABMT8 8 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
    <arm_group_label>Active ABMT8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active ABMT4</intervention_name>
    <description>Active ABMT4 4 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance</description>
    <arm_group_label>Active ABMT4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo: will receive 4 training sessions(10 min. each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  combat soldiers

        Exclusion Criteria:

          -  Fluent Hebrew
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yair Bar-Haim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eyal Fruchter</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mental Health Department IDF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IDF Military camps</name>
      <address>
        <city>Beer sheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6. Review.</citation>
    <PMID>20456540</PMID>
  </reference>
  <reference>
    <citation>Bar-Haim Y, Holoshitz Y, Eldar S, Frenkel TI, Muller D, Charney DS, Pine DS, Fox NA, Wald I. Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry. 2010 Jun;167(6):694-8. doi: 10.1176/appi.ajp.2009.09070956. Epub 2010 Apr 15.</citation>
    <PMID>20395400</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2012</study_first_submitted>
  <study_first_submitted_qc>November 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2012</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel Aviv University</investigator_affiliation>
    <investigator_full_name>Yair Bar-Haim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Attention bias modification</keyword>
  <keyword>resilience</keyword>
  <keyword>combat</keyword>
  <keyword>PTSD</keyword>
  <keyword>Depression</keyword>
  <keyword>Anxiety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

